A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

Authors:

Abstract
Diabetic cardiomyopathy describes heart disease in patients with diabetes who have no other cardiac conditions but have a higher risk of developing heart f
Funding Information
  • Baker Heart and Diabetes Institute (Women in Science Grant, Baker Fellowship)
  • Diabetes Australia (Y19G-BERB, Y19G-BERB)
  • National Heart Foundation of Australia (102539 (Future Leader Fellowship))
  • Monash University (Research Training Program scholarship)
  • National Health and Medical Research Council (1078985, 1117835, 2017070)
  • National Health and Medical Research Council

This publication has 53 references indexed in Scilit: